Mettler-Toledo International, Inc. $MTD Stock Sold by Boston Trust Walden Corp

Posted by Francis Steltz on Nov 5th, 2026

Boston Trust Walden Corp trimmed its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 3.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 81,483 shares of the medical instruments supplier’s stock after selling 2,903 shares during the period. Mettler-Toledo International makes up approximately 1.0% of Boston Trust Walden Corp’s investment portfolio, making the stock its 15th largest holding. Boston Trust Walden Corp’s holdings in Mettler-Toledo International were worth $123,117,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of MTD. North Dakota State Investment Board lifted its holdings in Mettler-Toledo International by 1.0% in the third quarter. North Dakota State Investment Board now owns 617 shares of the medical instruments supplier’s stock worth $932,000 after purchasing an additional 6 shares during the period. Plan A Wealth LLC grew its position in Mettler-Toledo International by 1.9% in the 3rd quarter. Plan A Wealth LLC now owns 373 shares of the medical instruments supplier’s stock valued at $564,000 after buying an additional 7 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Mettler-Toledo International by 0.3% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 2,794 shares of the medical instruments supplier’s stock valued at $4,222,000 after buying an additional 7 shares during the period. Torray Investment Partners LLC increased its stake in Mettler-Toledo International by 0.5% during the 1st quarter. Torray Investment Partners LLC now owns 1,677 shares of the medical instruments supplier’s stock valued at $2,115,000 after buying an additional 8 shares during the period. Finally, Frank Rimerman Advisors LLC raised its position in shares of Mettler-Toledo International by 2.2% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 372 shares of the medical instruments supplier’s stock worth $562,000 after buying an additional 8 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 942 shares of the business’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the sale, the chief executive officer directly owned 4,480 shares in the company, valued at approximately $6,384,000. The trade was a 17.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.71% of the company’s stock.

Mettler-Toledo International Trading Up 1.5%

Shares of Mettler-Toledo International stock opened at $1,723.17 on Thursday. The business has a fifty day simple moving average of $1,512.80 and a 200-day simple moving average of $1,343.25. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,737.99. The firm has a market cap of $34.53 billion, a price-to-earnings ratio of 37.83, a price-to-earnings-growth ratio of 3.42 and a beta of 1.16. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.

Analyst Ratings Changes

A number of analysts have commented on the stock. Morgan Stanley boosted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 13th. Royal Bank Of Canada started coverage on shares of Mettler-Toledo International in a report on Tuesday, September 1st. They issued a “sector perform” rating and a $1,515.00 price objective for the company. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Stifel Nicolaus boosted their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, August 3rd. Finally, Rothschild & Co Redburn assumed coverage on Mettler-Toledo International in a report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,469.15.

Read Our Latest Stock Report on MTD

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc (NYSE: MTD) develops and manufactures precision instruments and related services for laboratory, industrial, and retail applications. Its products help customers weigh, measure, analyze, inspect, and control materials and processes with high accuracy.

The company’s laboratory offerings include balances and scales, analytical instruments, titration and pH systems, thermal analysis equipment, spectroscopy products, laboratory automation solutions, and associated software.